Xilio Therapeutics Appoints Yariv J. Houvras, M.D., Ph.D. as Chief Medical Officer

Summary

Xilio Therapeutics appointed Yariv J. Houvras, M.D., Ph.D. as Chief Medical Officer. Dr. Houvras brings over two decades of executive leadership in clinical development, translational medicine, and immuno-oncology from industry and academic institutions.